Recombinant Human IFNA4 Protein，His

IFNA4, a member of the interferon alpha (IFN-α) family, plays a crucial role in the immune response, particularly in antiviral defense mechanisms. It is produced by various cell types, including leukocytes, in response to viral infections and serves as a signaling molecule, binding to specific receptors to activate a cascade of immune responses. The unique structure of IFNA4, along with its binding affinity and activity, makes it an important subject of research for therapeutic applications, particularly in the treatment of viral infections and cancer. Recent studies have focused on the recombinant expression of IFNA4 to produce it in larger quantities for detailed functional analyses and potential therapeutic uses. Advances in molecular biology techniques, such as genetic engineering and recombinant DNA technology, have enabled the efficient production of IFNA4 in host systems like bacteria or yeast. This allows for the investigation of its biological properties, including its efficacy in enhancing the immune response and its potential as an adjuvant in vaccine development. Additionally, understanding the mechanisms by which IFNA4 exerts its effects may help in the design of novel antiviral and anticancer therapies, taking advantage of its immunomodulatory functions. Overall, the ongoing research on IFNA4, with a focus on its recombinant protein forms, aims to illuminate its roles in immune regulation and unlock new avenues for clinical interventions.